Madrigal Pharmaceuticals
Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDGL
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A.
MDGL Key Statistics
Stock Snapshot
Madrigal Pharmaceuticals(MDGL) stock is priced at $467.54, giving the company a market capitalization of 10.8B. It carries a P/E multiple of -36.29.
On 2026-10-21, Madrigal Pharmaceuticals(MDGL) stock moved within a range of $448.34 to $470.08. With shares now at $467.54, the stock is trading +4.3% above its intraday low and -0.5% below the session's peak.
Trading volume for Madrigal Pharmaceuticals(MDGL) stock has reached 407.95K, versus its average volume of 335.83K.
Over the past 52 weeks, Madrigal Pharmaceuticals(MDGL) stock has traded between a high of $615.00 and a low of $393.61.
Over the past 52 weeks, Madrigal Pharmaceuticals(MDGL) stock has traded between a high of $615.00 and a low of $393.61.
MDGL News
Madrigal (MDGL) announced an update on their ongoing clinical study. The phase 4 study “Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidit...
Madrigal (MDGL) announced an update on their ongoing clinical study. The study “Resmetirom in Patients With MASH and HFpEF” tests Madrigal’s liver drug in peop...
Analyst ratings
95%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.